MENU
SNPHY
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Santen Pharmaceutical (SNPHY) Ownership - Who owns Santen Pharmaceutical?

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products... Show more

Profile

Industry
N/A
Address
Grand Front Osaka Tower A
Phone
+81 663217000
Employees
4073
Web
http://www.santen.co.jp

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
3.35B
P/E Ratio
17.48
Total Cash
66.08B
Projected Growth
N/A
Total Debt
N/A
Revenue
291.48B
Risk (Beta)
0.12
Dividend Yield
0.02
Total Cash/Share
205.44
Total Debt/Equity
N/A
Revenue/Share
5.51 USD as % of share price

Fundamentals

SNPHY
Capitalization
3.35B
P/E Ratio
17.48
Risk (Beta)
0.12
Dividend Yield
0.02
Total Cash
66.1B
Total Cash/Share
205.44
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.51%
Revenue
291B
ROE
N/A
Book Value
275B
P/B Ratio
1.90
Cash Flow
N/A
Earnings
92.86
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.82B
Current Ratio
2.65
Current Revenue Per Employee
21135684.00
Dividends Per Share - Security
N/A
EBITDA
52.9B
Float
N/A
Float - Current
N/A
Gross Income Margin
60.00
Revenue To Assets
7.87
Shares Held By Institutions
2.1M
Shares Outstanding - Current
322M
Total Liabilities
116B
Total Volume MTD
N/A
Value
1
Gain YTD
2.470
View a ticker or compare two or three
SNPHY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
Grand Front Osaka Tower A
Phone
+81 663217000
Employees
4073
Web
http://www.santen.co.jp